Search
Beta Bionics Inc
BBNXAdd to Watchlist
12.830USD
-1.440-10.09%
Close 07-31 16:00（ET）Quotes delayed by 15 min
577.22MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Beta Bionics Inc is 8.17, ranking 62 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 32.00, with a high of 35.00 and a low of 23.00.
Analyst Rating
Based on
11
analysts
Buy
Current Rating
20.082
Target Price
+56.52%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
88
Total
4
Median
7
Average
Company name
Ratings
Analysts
Beta Bionics Inc
BBNX
11
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
33
Veeva Systems Inc
VEEV
30
Thermo Fisher Scientific Inc
TMO
30
1
2
3
...
18
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Beta Bionics Inc's expected revenue for the next quarter?
Beta Bionics Inc's expected revenue is 35.13M.
What is Beta Bionics Inc's price target?
Analysts forecast that Beta Bionics Inc's price target is USD 32.00, with the highest forecast at USD 35.00 and the lowest forecast at USD 23.00.
How have Beta Bionics IncBBNX's recent earnings per share performed?
The market expectation was USD -0.53, while Beta Bionics IncBBNX's earnings per share (EPS) for the previous quarter was USD -0.49. EPS for the next quarter is expected at USD -0.55.
What is the analyst rating for Beta Bionics Inc?
Based on the ratings of Beta Bionics Inc's stock from 11 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.